? e-coli ?
https://www.google.com/search?q=antibacterial+resistant+bacteria+e-coli+from+human+feces&rlz=1C1CHZN_enNZ947NZ947&ei=PFSwZOmjA8XV1e8Px_ausAw&ved=0ahUKEwjpscWKuYyAAxXFavUHHUe7C8YQ4dUDCBA&uact=5&oq=antibacterial+resistant+bacteria+e-coli+from+human+feces&gs_lcp=Cgxnd3Mtd2l6LXNlcnAQAzIFCAAQogQyBQgAEKIEMgUIABCiBDIFCAAQogQyBQgAEKIEOgoIABBHENYEELADSgQIQRgAUJRgWOF4YLl8aANwAHgAgAHWAYgBjgaSAQUwLjIuMpgBAKABAcABAcgBCA&sclient=gws-wiz-serp
https://www.pharmaceutical-technology.com/uncategorized/recce-327-recce-pharmaceuticals-escherichia-coli-infections-likelihood-of-approval/
.
- Forums
- ASX - By Stock
- RCE
- Ann: First Cohort Dosed in Rapid Infusion Phase I/II UTI study
Ann: First Cohort Dosed in Rapid Infusion Phase I/II UTI study, page-16
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
54.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $126.3M |
Open | High | Low | Value | Volume |
55.5¢ | 55.5¢ | 54.0¢ | $17.46K | 31.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13261 | 54.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.0¢ | 10024 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13261 | 0.545 |
1 | 79436 | 0.540 |
2 | 20935 | 0.535 |
2 | 82723 | 0.530 |
1 | 500 | 0.520 |
Price($) | Vol. | No. |
---|---|---|
0.550 | 10024 | 4 |
0.555 | 24067 | 2 |
0.565 | 5000 | 1 |
0.570 | 54708 | 3 |
0.580 | 1290 | 1 |
Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online